PERSPECTA

News from every angle

← Back to headlines

OneSource Specialty Pharma Bets on GLP-1 Drug Market Growth

OneSource Specialty Pharma is making a capacity-led investment, positioning itself to capitalize on the growing market for GLP-1 drugs.

9 May, 02:00 — 9 May, 02:00
PostShare

Sources

Showing 1 of 1 sources
indian-expressMostly Factual1h ago

OneSource Specialty Pharma: A capacity-led bet on the GLP-1 gold rush

By Rahul Rao

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Mom, mama, nanay: The heroes that save homes when economic crisis hits

just now

NBI arrests five over unfair competition and misuse of La Union grape brand

just now

Toll collection begins at Cavitex C5 Link-Segment 3B

just now